Track 12: Cancer Genomics & Metabolomics
Oncogenomics is a sub-field of genomics that characterizes cancer-associated or cancer related genes. It focuses mainly on genomic, epigenomic and transcript alterations in cancer. The main concept and idea of oncogenomics is to check new group of oncogenes or tumor suppressor genes that may give new areas of research into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The Gleevec, Herceptin and Avastin are the targeted cancer therapies which gave a new way for oncogenomics to elucidate new targets for cancer treatment. The metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism that are the end biology.
Related Conference of Track 12: Cancer Genomics & Metabolomics
July 20-21, 2026
13th International Conference on Medicinal Practices: Herbal, Holistic and Traditional
Paris, France
August 27-28, 2026
16th International Conference on Preventive Medicine & Public Health
Berlin, Germany
September 07-08, 2026
12th International Conference on Advances Healthcare and Medical Science
Barcelona, Spain
September 28-29, 2026
13th International Conference on Stroke and Neurological Disorders
Amsterdam, Netherlands
October 22-23, 2026
9th European Conference on Public Health, Well-being and Healthcare Management
Paris, France